Evoke Pharma Inc expected to post a loss of 53 cents a share - Earnings Preview

Evoke Pharma

17/03/2023 21:15

* Evoke Pharma Inc  EVOK.OQ   EVOK.O  is expected to show a
rise
in quarterly revenue when it reports  results on March 21. 
    * The Solana Beach California-based  company is expected to
report
 a 146.9% increase in revenue to $889 thousand from $360
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Evoke Pharma Inc is
for a
loss of 53 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Evoke
Pharma Inc
is $7​, above​ its last closing price of $3.32. ​​​

This summary was machine generated March 17 at 21:15 GMT.  All
figures in US dollars  unless otherwise stated